Clinical trial
A Randomized Phase III Double-Blind Study Of Ondansetron And Dexamethasone Versus Ondansetron And Placebo In The Prophylaxis Of Radiation-Induced Emesis
NCT00016380 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase III Double-Blind Study Of Ondansetron And Dexamethasone Versus Ondansetron And Placebo In The Prophylaxis Of Radiation-Induced Emesis
- Lead sponsor
- NCIC Clinical Trials Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2001
- Completion date
- February 10, 2009
- Enrollment
- 211 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
cancer